Technology | 2009.10.19
Verdezyne Receives Federal Grant to Advance Synthetic Biology Tools
CARLSBAD, Calif.--(BUSINESS WIRE)--Verdezyne, Inc., a privately-held synthetic biology company developing fermentation processes for industrial chemicals and biofuels, announced today that they have been awarded a $1.7 million grant from the National Institute of Allergy And Infectious Diseases (NIAID) for a period of 1.5 years. The goal of this program is to quickly and reliably advance the construction of directed mutant gene libraries widely considered important technology tools for synthetic
For more information, please visit
http://www.businesswire.com/news/home/20091019005856/en
